Dr. John Ardis Linfoot Jr., M.D., M.P.H. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: Brooke Army Medical Center, Mche-qd/ Credentials, 3851 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-5250 Fax: 210-916-1602 |
Bryce Warren, MD, PHD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-202-5077 |
Dr. Craig Russell Ainsworth, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-2460 |
Dr. James Michael Lamiell, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Mche-qd/credentials, Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-916-2460 |
Dr. Michael James Morris, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-916-2222 Fax: 210-916-5187 |
News Archive
Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al, "Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry," appears in the March 2010 issue of the Journal of Molecular Diagnostics.
IASIS Healthcare today announced the signing of a definitive agreement to acquire Brim Holdings, Inc., which operates Wadley Regional Medical Center in Texarkana, Texas, and Pikes Peak Regional Hospital in Woodland Park, Colorado, in a cash-for-stock transaction valued at approximately $95 million, subject to customary closing conditions and working capital adjustments. Combined revenue of the two facilities is approximately $120 million.
A new study suggests that treatment of mild sleep-disordered breathing with continuous positive airway pressure (CPAP) therapy in pregnant women with preeclampsia improves fetal activity levels, a marker of fetal well-being.
ADVENTRX Pharmaceuticals, Inc. announced today that it met with the U.S. Food and Drug Administration (FDA) to review development plans for ANX-188 (purified poloxamer 188), the Company's first-in-class treatment for sickle cell patients experiencing vaso-occlusive crisis.
A team of Duke Medicine researchers has engineered cartilage from induced pluripotent stem cells that were successfully grown and sorted for use in tissue repair and studies into cartilage injury and osteoarthritis.
› Verified 6 days ago